Introduction
Since 1882, numerous clinical and laboratory studies have defined the importance of Staphylococcus aureus as the causative agent for a wide spectrum of human and veterinary infections [1, 2] , including its role in sepsis and abscess formation. Nowadays, infections caused by anti-biotic-resistant strains of S. aureus, such as community-acquired methicillin-resistant S. aureus (CA-MRSA), have reached epidemic proportions globally. In addition to their increasing prevalence and incidence, CA-MRSA strains appear to be especially virulent, leading to overwhelming and tissue-destructive infections, such as necrotizing fasciitis and fulminant, necrotizing pneumonia [3, 4] .
S. aureus pathogenesis is complex and multifactorial as the organism expresses numerous virulence factors which can act either alone or in concert to induce various pathogenic conditions [2] . Among its virulence factors, S. aureus produces a wide variety of exoenzymes, including nucleases, proteases, lipases, hyaluronidase and collagenase [5] . These enzymes have the ability to generate bacterial nutrients by host tissue breakdown and thereby promote bacterial growth and increase invasive disease potential [6, 7] .
Although expression and secretion of an extracellular nuclease by S. aureus have been documented for a long time [8] [9] [10] , the specific role of S. aureus nuclease in pathogenesis is poorly understood. Recently, its contribution in biofilm formation was investigated [11] . The authors showed that a nuclease-deficient ( nuc -deficient) mutant formed a thicker biofilm containing increased levels of matrix-associated released DNA. Therefore, one potential contribution of nuclease expression by S. aureus is involvement in biofilm dispersal and subsequent promotion of bacterial spreading [11] .
A major new paradigm regarding host innate immune defense against bacterial pathogens is the function of neutrophil extracellular traps (NETs). Released at sites of infection by activated neutrophils, NETs consist of nuclear or mitochondrial DNA as a backbone with embedded antimicrobial peptides, histones and cell-specific proteases and thereby provide an extracellular matrix to entrap and kill various microbes [12] . Recently, the ability of the important Gram-positive bacterial pathogens group A Streptococcus and Streptococcus pneumoniae to resist NET-dependent killing has been linked to their ability to secrete nucleases, a phenotype that contributes to the pathogenesis of necrotizing soft tissue infection (group A Streptococcus ) or pneumonia (S. pneumoniae) in corresponding animal models of infection [13] [14] [15] .
Here we investigated whether S. aureus nuclease expression could promote NET evasion and thereby contribute to disease pathogenesis, using isogenic bacterial mutant strains, fluorescence microscopy-based in vitro assays and a murine model of S. aureus respiratory tract infection.
Materials and Methods
Bacterial Strains and Mutants S. aureus strain LAC (pulsed-field type USA300), a community-acquired CA-MRSA strain, was used in this study [16] . The USA300 clone of MRSA is epidemic in the United States and is associated with skin infection [17, 18] , necrotizing fasciitis [19] and severe pneumonia [20] , often in previously healthy individuals. We used a panel of nuc -deficient mutants and control strains ( table 1 ) [21] to study the effect of nuclease expression on virulence. Bacteria were grown in Brain-Heart Infusion (BHI) medium at 37 ° C with shaking. Fresh overnight cultures were diluted 1: 100 in BHI and then grown to mid-logarithmic growth phase (OD 600 = 0.7) for use in in vitro and in vivo experiments. Bacterial suspensions were used directly for in vitro experiments by diluting the bacteria in respective cell culture media to the desired concentration. For in vivo experiments, the bacteria were centrifuged at 4,000 rpm for 10 min and the pellet was resuspended in sterile phosphate-buffered saline (PBS) to reach the desired bacterial concentration.
Nuclease Assays
To measure nuclease activity, supernatants from the panel of S. aureus strains ( table 1 ) were harvested from mid-logarithmic growth cultures (OD 600 = 0.7) after centrifugation for 10 min at 4,000 rpm. A volume of 2.5 l of the supernatant or sterile BHI (negative control) was incubated with 7.5 l calf thymus DNA (1 mg/ml, Sigma) and 40 l DNase buffer (3 m M MgCl 2 , 3 m M CaCl 2 , 300 m M Tris; pH 7.4) for 60 min at 37 ° C. The nuclease reaction was stopped with 12.5 l 0.33 M EDTA (pH 8.0), then 12.5 l 6 ! loading dye was added and 20 l of each sample was run on a 1% agarose gel for visual examination of DNA degradation. Neutrophil Killing Assays Human neutrophils were isolated from healthy donors by using the PolymorphPrep system (Axis-Shield). Neutrophils were resuspended in RPMI containing 2% nuclease-free (heat-inactivated at 70 ° C [22] ) fetal calf serum (FCS) and plated in nontreated tissue culture plates (Greiner Bio-One, Cellstar ) at a concentration of 2 ! 10 6 cells/ml. The cells were treated with 10 g/ml cytochalasin D (Sigma-Aldrich) to block phagocytosis and with 25 n M phorbol 12-myristate 13-acetate (PMA) to stimulate NET formation. After incubation for 20 min at 37 ° C in 5% CO 2 , the neutrophils were infected with bacteria at a multiplicity of infection (MOI) of 2. The plates were centrifuged at 1,600 rpm for 5 min and incubated for 30 and 90 min at 37 ° C in 5% CO 2 . Serial dilutions in sterile PBS were plated on Todd-Hewitt agar plates for enumeration of surviving bacteria. The percentage of surviving bacteria was calculated in comparison to bacterial growth control grown under the same conditions in the absence of cells.
NET Entrapment Assays
A volume of 10 ml bacteria at OD 600 = 0.7 was incubated in the presence of 0.33 mg/ml fluorescein-5-isothiocyanate (FITC isomer I, Invitrogen) for 30 min on ice. Human neutrophils were resuspended in RPMI without phenol red containing 2% nuclease-free FCS and plated in nontreated tissue culture plates at a concentration of 2 ! 10 6 cells/ml. Cells were stimulated with 25 n M PMA for 20 min at 37 ° C in 5% CO 2 , then infected with bacteria at a MOI of 200, and incubated for 90 min at 37 ° C in 5% CO 2 . After incubation, the plate was centrifuged at 800 rpm for 5 min. From the wells containing neutrophils, the supernatant was carefully aspirated and fresh, prewarmed medium was added. This washing procedure was done twice to remove bacteria that were not entrapped within the NETs. Fluorescence was measured with a fluorescence reader at 485/538 nm. The percentage of entrapped bacteria was calculated as (A458/538 of wells containing neutrophils)/(A458/538 of wells without neutrophils) ! 100.
NET Visualization and Quantification
Neutrophils were seeded on poly-L -lysine-coated cover slides and stimulated with 25 n M PMA for 20 min at 37 ° C in 5% CO 2 . The cells were infected with S. aureus at a MOI of 2, centrifuged at 1,600 rpm for 5 min and incubated for 90 min at 37 ° C in 5% CO 2 . After incubation, cells were fixed with 4% paraformaldehyde, washed with PBS and blocked with 2% whole goat serum (MP Biomedicals) in PBS + 2% BSA for 45 min at room temperature. To visualize NETs, the slides were incubated for 1 h at room temperature with antibodies against myeloperoxidase (MPO, rabbit anti-MPO, 1: 300 diluted, Dako) and against histone H2A-H2B-DNA complex (mouse monoclonal anti-H2A-H2B-DNA, PL2-6, stock 2.65 mg/ml, 1: 3,000 diluted) [23] . After incubation, the slides were washed 3 times with PBS and incubated for 45 min at room temperature with secondary antibodies, Alexa fluor 488 goat anti-rabbit IgG (1: 500, Invitrogen) or Alexa fluor 488 rabbit anti-mouse IgG (1: 500, Invitrogen). After washing, the slides were mounted on glass slides using Prolong Gold with 4',6'-diamidino-2-phenylindole (DAPI) (Invitrogen). Washing steps were conducted with PBS and the antibodies were diluted in 2% BSA-PBS (for MPO staining) and 2% BSA-PBS + 0.2% Triton X-100 (for H2A-H2B-DNA complex staining). Mouse IgG2b (Thermo Scientific) and rabbit IgG (Jackson) were used as respective isotype control antibodies. Images were recorded using a Zeiss Axiolab microscope (Zeiss 20 ! /0.5 Plan-Neofluar objective) with an attached Sony Digital Photo Camera DKC-5000. The total amount of neutrophils and the amount of neutrophils releasing NETs per field of view were counted in 6 individual images per sample. The proportion of NETs per total amount of neutrophils was calculated for comparison of NET degradation by different bacterial strains.
Microscopy to Determine Killing of Bacteria in NETs
To determine the viability of S. aureus entrapped within NETs, neutrophils were seeded, stimulated and infected as described above. After 30 min of incubation, the cells were washed and the Live/Dead BacLight TM Bacterial Viability Kit (Invitrogen) used according to the manufacturer's recommendations. After staining for 15 min at room temperature, the slides were washed with PBS and fixed with 1% paraformaldehyde for 5 min at room temperature. Then the slides were washed again 3 times with PBS and mounted in Prolong Gold with DAPI (Invitrogen). The samples were analyzed using a confocal laser-scanning 2-photon microscope: Fluoview FV1000 with FluoView TM Spectral Scanning technology (Olympus). Images were recorded using 20 ! /0.7 UPlanSAp, 40 ! /1.30 oil UPlanFLN or 60 ! /1.42 oil PlanApoN objectives at calibrated magnifications.
In vivo Mouse Model
An established mouse model of S. aureus respiratory tract infection [24, 25] was used to analyze the in vivo impact of S. aureus nuclease. Outbred, 8-week old-female CD1 mice were obtained from Charles River Laboratories and housed for a minimum of 3 days after shipping prior to the start of each experiment. Mice were anesthetized with an intraperitoneal injection of 50 mg/kg ketamine and 5 mg/kg rompun and then infected intranasally with wild-type or nuc -mutant bacteria. For histological studies and to determine bacterial load in lung tissue, the animals were infected with a sublethal dose of 2 ! 10 8 colony-forming units (CFU) in 30 l PBS. Twenty-four hours after infection, the lungs were inflated via the trachea with 10% paraformaldehyde and fixed overnight for histological examination. For determination of bacterial load, the lungs were removed 6 and 24 h after infection and homogenized in PBS for 2 ! 1 min using zirconia beads (1 mm, Biospec) in a Mini-Beadbeater (BioSpec Products). Serial dilutions in sterile PBS were plated on Todd-Hewitt Agar plates for enumeration of CFU. For determinations of survival curves, the animals were infected with 3 or 4 ! 10 8 CFU in 30 l PBS and mortality was recorded.
Immunohistochemistry
Lung samples were kept in 70% ethanol prior to embedding in paraffin. Sections (7 m thick) were deparaffinized by immersing successively in 3 changes of xylene for 10 min each and rehydrated by immersing in decreasing concentrations of ethanol (100, 95, 70%, each twice for 5 min). After washing 3 times with PBS, antigen retrieval was performed by microwave-heating the slides for 2 ! 5 min in citrate buffer (10 ! Antigen retrieval solution, Dako). After cooling down for 20 min at room temperature, the slides were washed with PBS, and immunostained overnight at 4 ° C with primary antibodies against rabbit anti-murine cathelicidin (CRAMP, stock 1.55 mg/ml, 1: 300 diluted, provided by Richard Gallo, UCSD, Calif., USA [26] ) and mouse anti-H2A-H2B-DNA complex antibody (stock 2.65 mg/ml, 1: 3,000 diluted [23] ) or respective isotype controls (rabbit IgG whole molecule, Jackson ImmunoResearch, and mouse IgG2b, Thermo Scientific). After washing 3 times with PBS, slides were incubated with secondary antibodies Alexa 568 goat anti-rabbit (Invitrogen, 1: 500) and Alexa 488 goat anti-mouse (Invitrogen, 1: 500) for 1 h at room temperature. After washing 3 times, the sections were mounted on glass slides using Prolong Gold with DAPI (Invitrogen).
Statistical Analysis
Data were analyzed by using Excel 2003 (Microsoft) and GraphPad Prism 5.0 (GraphPad Software). Experiments were performed in triplicate or quadruplicate in at least 3 independent experiments. Differences between 2 groups in vitro were analyzed by using a paired, one-tailed Student's t test. For in vivo data, significant outliers were excluded using the Grubbs' test (GraphPad software) and normal distribution of data was verified by D'Agostino and Pearson omnibus normality test (GraphPad software) prior to statistical analysis. Differences between 2 groups were then analyzed using an unpaired, one-tailed Student's t test. Analysis of survival curves was performed by the use of the Gehan-Breslow-Wilcoxon test (GraphPad software). p ! 0.05 was considered to be significant.
Results

S. aureus Nuclease Promotes Degradation of Calf
Thymus DNA Using targeted mutagenesis, nuclease gene mutants of the CA-MRSA strain LAC were generated as described elsewhere [21] . To assess interaction with host DNA, bacterial supernatant was collected and the nuclease activity was tested in an agarose-gel-based DNA degradation assay. As shown in figure 1 a, the nuc-mutant strains ( nuc and nuc + pCM28 empty vector control) exhibited no nuclease activity. Sterile BHI medium alone was used as negative control. In contrast, supernatants from the wildtype strain (wt) and its respective vector control (wt + pCM28) or complemented strain (nuc + pCM28 nuc) efficiently degraded calf thymus DNA ( fig. 1 a) .
S. aureus Nuclease Promotes Degradation of NETs
To test whether S. aureus is able to degrade NETs via its nuclease activity, neutrophils were stimulated with PMA for NET induction and then incubated in the presence of wild-type or nuc -mutant bacteria ( table 1 ) . After 90 min of coincubation, neutrophils infected with wildtype bacteria showed no intact NETs whereas approximately 70% of the neutrophils treated with nuc mutant were associated with intact NETs ( fig. 1 b, c) . Control experiments analyzing the release of lactate dehydrogenase as marker for cytotoxicity and elastase as marker for neutrophil activation did not reveal significant differences between the strains (online supplementary figure 1, www.karger.com/doi/10.1159/000319909), indicating that S. aureus nuclease has no effect on cytotoxicity or activation of neutrophils. We conclude that the nuclease is efficiently degrading NETs.
S. aureus Nuclease Mediates Resistance against Entrapment and Killing within NETs
NETs have been shown to mediate their antimicrobial activity through (1) bacterial entrapment and (2) subsequent direct bacterial killing by antimicrobial peptides and histones which are embedded in the NETs or accumulated in close proximity to the cell [27] . As shown in figure 2 a, significantly more nuc -mutant bacteria are found to be entrapped by NETs compared with wild-type bacteria, which have the ability to degrade the NETs ( fig. 1 b, c) . The few remaining NETs that are not eliminated by the wild-type strain have the same capability to capture bacteria as NETs coincubated with the nucmutant strain (online suppl. fig. 2 ). However, a nucleasedependent reduction in total NET surface area, as shown in figure 1 b, c, allows the wild-type bacteria to largely (For figure see next page.) Fig. 1 . S. aureus nuclease degrades calf thymus DNA and NETs. a Representative agarose gel of bacterial culture supernatants after incubation with calf thymus DNA to detect nuclease activity. Samples with nuclease activity show a smear of degraded DNA on the gel as is seen in the lanes representing the S. aureus LAC wild-type empty vector control (wt + pCM28), complemented nuc -mutant strain (nuc + pCM28 nuc) and wild-type (no vector, wt). In the lanes with samples from nuc -mutant empty vector control ( nuc + pCM28), nuc -mutant (no vector, nuc ) and sterile BHI medium (negative control), the DNA is not degraded, indicating that no nuclease activity is present. b Quantification of NETs after coincubation of PMA-stimulated neutrophils with S. aureus LAC wild-type empty vector control (wt + pCM28), nuc -mutant empty vector control ( nuc + pCM28) or complemented mutant strain (nuc + pCM28 nu c ) , wild-type (no vector, wt) or nuc -mutant (no vector, nuc ) at a MOI of 2 for 90 min. After coincubation, the slides were fixed and stained for MPO to visualize the NETs and mounted in DAPI to stain DNA. The amount of neutrophils that release NETs was counted per field of view and compared with the total amount of neutrophils. The results of 4 (wt + pCM28, nuc + pCM28, nuc + pCM28 nuc ) or 3 (wt, nuc ) independent experiments were analyzed using a paired, one-tailed Student's t test. * p ! 0.05; * * p ! 0.01. c Representative immunofluorescent micrograph of PMA-stimulated neutrophils coincubated with S. aureus LAC wild-type empty vector control (wt + pCM28), nuc -mutant empty vector control ( nuc + pCM28) or complemented mutant strain (nuc + pCM28 nu c). NETs were visualized with a primary rabbit-anti-MPO antibody and a secondary Alexa 488-labeled goat-anti-rabbit antibody (green). DNA is stained with DAPI (blue). was used to determine the viability of bacteria after coincubation with stimulated neutrophils. Similar bacterial killing within remaining NETs has been detected in case of the wild-type strain (data not shown). The green dye (SYTO 9) generally labels all bacteria -bacteria with intact as well as damaged membranes. In contrast, the red dye (propidium iodide) penetrates only bacteria with damaged membranes, causing a reduction in the green (SYTO 9) fluorescence stain. Note that bacteria entrapped by or in close proximity to the NETs are dead (red + green) whereas bacteria that are further away from the NETs remain alive (green, white arrow).
avoid entrapment ( fig. 2 a) and subsequent killing within NETs. As confirmed in figure 2 b, bacteria that are entrapped by NETs can be efficiently killed through accumulating concentrations of antimicrobial peptides and histones within NETs or surrounding the cell. Finally, the overall bacterial viability of wild-type and nuc -mutant bacteria was quantified by enumerating the surviving bacteria after coincubation with activated neutrophils for 30 or 90 min. Using a total neutrophilkilling assay, the nuc -mutant exhibited a slight but significant increased susceptibility to neutrophil killing compared with the parental strain. The difference between wild-type and complemented strain was not significant (online suppl. fig. 3 ). However, when neutrophils were treated with cytochalasin D to block phagocytosis, but not the formation of NETs ( fig. 3 a) , the differences between wild-type, nuc -mutant and complemented strains became more distinct. As shown in figure 3 b, the nuc -mutant strain is significantly more susceptible to the extracellular antimicrobial activity of neutrophils compared with the NETs were visualized using a triple-staining of DAPI to stain DNA (blue), monoclonal mouse anti-H2A-H2B-DNA complex antibody followed by an Alexa 488-goatanti-mouse antibody (green) and rabbitanti-CRAMP antibody followed by Alexa 568-goat-anti-rabbit antibody (red).
wild-type and complemented strains ( fig. 3 b) , demonstrating that nuclease efficiently mediates resistance against entrapment and subsequent killing within NETs.
Role of S. aureus Nuclease in Respiratory Tract
Infection Nearly 3 decades ago, Nugent and Pesanti [28] reported that S. aureus is cleared from the lungs of infected mice by an unidentified extracellular killing mechanism. Based on this discovery, we decided to investigate the presence and role of NETs in an established murine model for respiratory tract infection described by Bubeck Wardenburg et al. [24, 25] . Using immunofluorescence microscopy, we identified NET formation in the alveolar space of mouse lungs 24 h after intranasal infection with 2 ! 10 8 CFU of S. aureus strain LAC ( fig. 4 ) . PBS-treated mice were used as negative control and exhibited no NET formation in the lung tissue ( fig. 4 ) .
Having confirmed the presence of NETs in vivo, we analyzed the effect of nuclease-mediated NET degradation on S. aureus pathogenesis using the above-mentioned animal model. Mice were intranasally infected with a sublethal dose of 2 ! 10 8 CFU wild-type or nucmutant bacteria and bacterial load in the lung tissue was quantified at 6 and 24 h after infection. Control experiments confirmed that the nu c mutation is stable in vivo (online suppl. fig. 4) , as shown by a nuclease degradation assay with bacteria recovered at 24 h after infection. At 6 h after infection we found similar amounts of wild-type and nuc bacteria in the lungs of infected mice ( fig. 5 a) . However, after 24 h, nearly 1 log-fold more bacteria were recovered from the lungs of wild-type infected mice compared with mice infected with the nuc -mutant strain ( fig. 5 a) . These results suggest nuclease production impairs S. aureus clearance from lung tissue.
Finally, to examine the overall virulence contribution of nuclease production, mice were infected with a lethal dose of 4 ! 10 8 CFU wild-type or nuc -mutant bacteria to score mortality within 5 days after intranasal infection. As shown in figure 5 b, wild-type mice exhibited a slightly, but significantly (p = 0.037) faster mortality rate compared with mice infected with nuc -mutant bacteria.
In conclusion our data revealed that S. aureus nuclease facilitates escape from NET-mediated killing by neutro- phils and thereby impairs an important host immune defense mechanism required for efficient clearance of the pathogen.
Discussion
Neutrophils are the principal phagocytic cells of humans and other mammals and have been shown to be essential in host immune defense against staphylococcal infections [29] . Classically, two mechanisms were considered to mediate the direct antimicrobial activity of neutrophils. Neutrophils can recognize, bind, engulf and subsequently inactivate the invading microbes within phagolysosomes. Alternatively, neutrophil degranulation can release antimicrobial factors of the cell into the surroundings. Only recently has a third and novel mechanism of antimicrobial activity of neutrophils been recognized, originally described in the landmark study of Brinkmann et al. [27] , namely the formation of NETs. Evidence is now accumulating indicating that extracellular trap formation is a feature of other immune cells including mast cells [30] and eosinophils [31] . Extracellular traps develop after stimulation with mitogens, cytokines, or pathogens themselves, in a process dependent upon induction of a reactive-oxygen-species-mediated signaling cascade. Extracellular traps can consist of nuclear or mitochondrial DNA as a backbone with associated antimicrobial peptides, histones and cell-specific proteases, which provide a matrix to entrap and kill microbes [12] .
Recently, in vitro analyses have shown that NETs are effective in entrapment and killing of S. aureus [27, 32] ( fig. 3 b) . Using immunofluorescence microscopy, we have confirmed the presence of NETs in the lung tissue of S. aureus-infected mice, indicating that NETs are produced in vivo in response to S. aureus infection and may therefore contribute to host immune defense [27, 32] ( fig. 3 b) . Indeed, these may now be considered to represent an important component of the nonphagocytic, extracellular clearance of S. aureus from lungs observed by Nugent and Pasani [28] in an earlier study.
Certain leading bacterial pathogens have evolved mechanisms to avoid NET-based immune clearance, either through NET degradation [13] [14] [15] , resistance to the intrinsic antimicrobial effectors within NETs [33, 34] , or the suppression of NET production [35] . In fact, experiments based on the manipulation of the microbial side of the host-pathogen interaction have provided one of the best demonstrations of a critical role of NETs in innate host defense [12] .
In the present study, we have used an isogenic nuclease mutant of S. aureus to show that the pathogen uses nuclease expression to reduce its entrapment by NETs and build up relative resistance against killing by NETs. Whole-blood killing experiments using opsonized bacteria did not reveal any significant differences between the wild-type and mutant strains (data not shown), suggesting that nuclease is only mediating resistance to extracellular NET-mediated killing but not to intracellular killing within phagocytes.
S. aureus nuclease production was found to be associated with delayed bacterial clearance in the lung and significantly increased mortality using a well-established model for S. aureus respiratory tract infections [24, 25] . Accordingly, S. aureus joins other leading Gram-positive pathogens, such as group A Streptococcus and S. pneumoniae, which facilitate their own NET evasion through nuclease production. Drugs that inhibit nuclease activity, induce or stabilize NET formation may support host immune defense and help to improve the outcome of bacterial infection with S. aureus and other common pathogens.
